YAP/TAZ‐TEAD as an Executor of Focal Adhesion Mechanotransduction Suppressed by the Hippo Pathway
Although the Hippo pathway is a well‐established negative regulator of the YAP/TAZ–TEAD1–4 transcriptional complex, the molecular mechanisms that actively sustain YAP/TAZ–TEAD activation remain poorly defined. Integrating recent literature with systematic Cancer Dependency Map (DepMap) codependency analysis, we propose a working model wherein the TAZ/YAP–TEAD complex functions as a nuclear executor of the focal adhesion mechanotransduction cascade. This mechanotransduction arm is predicted to initiate at the plasma membrane by integrins α v β 5 (ITGAV/ITGB5), N‐cadherin (CDH2), and lysophosphatidic acid receptor 1 (LPAR1), which likely engage PKN2 and MARK2/3 signaling kinases downstream of the focal adhesion complex. Conversely, a cell‐surface triad comprising NRP1, PLXNA1, and KIRREL1 and EPHA2 may act as an upstream activator of the inhibitory Hippo pathway. Collectively, we propose that TAZ/YAP–TEAD activity is governed by a dynamic, reciprocal antagonism between the Hippo pathway and focal adhesion‐mediated mechanotransduction, with the latter serving as a positive driver sustaining YAP/TAZ functional activity.
Authors
- Wanjin Hong (ORCID: https://orcid.org/0000-0002-1719-8960)
Institutions
- Agency for Science, Technology and Research (SG)
Publication Details
- Journal
- Advanced Science
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1002/advs.78240
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00